Cogent Biosciences (COGT) Shares Outstanding (Weighted Average): 2017-2021
Historic Shares Outstanding (Weighted Average) for Cogent Biosciences (COGT) over the last 4 years, with Dec 2021 value amounting to $39.9 million.
- Cogent Biosciences' Shares Outstanding (Weighted Average) rose 251.35% to $39.9 million in Q4 2021 from the same period last year, while for Sep 2021 it was $39.8 million, marking a year-over-year increase of 316.58%. This contributed to the annual value of $110.5 million for FY2024, which is 28.26% up from last year.
- Per Cogent Biosciences' latest filing, its Shares Outstanding (Weighted Average) stood at $39.9 million for Q4 2021, which was up 0.01% from $39.8 million recorded in Q3 2021.
- Cogent Biosciences' 5-year Shares Outstanding (Weighted Average) high stood at $39.9 million for Q4 2021, and its period low was $7.4 million during Q4 2017.
- Over the past 3 years, Cogent Biosciences' median Shares Outstanding (Weighted Average) value was $8.7 million (recorded in 2020), while the average stood at $18.5 million.
- Data for Cogent Biosciences' Shares Outstanding (Weighted Average) shows a peak YoY spiked of 393.04% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows Cogent Biosciences' Shares Outstanding (Weighted Average) stood at $7.4 million in 2017, then increased by 1.36% to $7.5 million in 2018, then rose by 2.25% to $7.7 million in 2019, then surged by 47.96% to $11.3 million in 2020, then skyrocketed by 251.35% to $39.9 million in 2021.
- Its last three reported values are $39.9 million in Q4 2021, $39.8 million for Q3 2021, and $38.4 million during Q2 2021.